Nateglinide

那格列奈

Report date: 2024/02/21 12:08:03
NME

Base Information

Drug NameNateglinide
Drug Alias NameGlinate那格尼奈那格列萘Senaglinidenateglinida +[18] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPotassium channel blockersVoltage-gated potassium channel blockers
TargetsPotassium channelVoltage-gated potassium channel
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsDiabetes Mellitus, Type 2
Approved Indications in ChinaDiabetes Mellitus, Type 2
Original Approved Country/TerritoryJapan
Original Approved Date1999/06/16
Country/TerritoryUnited StatesEUMainland China +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAjinomoto Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesJiangsu Deyuan Pharmaceutical Co Ltd
Inactive CompaniesNovartis Pharmaceuticals CorpNovartis Europharm LtdDr.Reddy's Laboratories Ltd
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeA10BX03
Related LinksWikipediaDrugBankKEGG